Does MKDWELL MKDW stock justify its valuation V Visa notches 48 percent Q1 2026 EPS beat yet shares fall 15 percent in todays trading session CI Cigna shares climb 26 percent despite posting a narrow Q4 2025 EPS miss against analyst estimates NPK National shares drop 429 on Q3 2023 earnings release despite posting 099 per share earnings Merck Co Inc MRK Implications of Partner AstraZenecas Q1 2026 Earnings Beat for Oncology Portfolio Trajectory KAI Kadant shares drop 425 percent even as Q4 2025 earnings per share exceed analyst forecasts Lee LEE EPS surges 83 past estimates despite revenue decline yet shares retreat 18 NVCT Nuvectis Pharma posts narrow Q4 2025 EPS miss edging down 023 in muted investor reaction